GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Cyclically Adjusted PB Ratio

Beximco Pharmaceuticals (DHA:BXPHARMA) Cyclically Adjusted PB Ratio : 1.02 (As of Jun. 05, 2025)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2025-06-05), Beximco Pharmaceuticals's current share price is BDT87.40. Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was BDT86.05. Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 1.02.

The historical rank and industry rank for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

DHA:BXPHARMA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.3   Max: 3.03
Current: 0.98

During the past years, Beximco Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 3.03. The lowest was 0.58. And the median was 1.30.

DHA:BXPHARMA's Cyclically Adjusted PB Ratio is ranked better than
73.12% of 703 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs DHA:BXPHARMA: 0.98

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Beximco Pharmaceuticals's adjusted book value per share data for the three months ended in Dec. 2024 was BDT111.354. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is BDT86.05 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Beximco Pharmaceuticals Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 2.10 2.01 1.91 1.42

Beximco Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.43 1.42 0.86 0.95

Competitive Comparison of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=87.40/86.05
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Beximco Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=111.354/133.1571*133.1571
=111.354

Current CPI (Dec. 2024) = 133.1571.

Beximco Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201409 46.055 100.428 61.064
201412 46.897 99.070 63.033
201503 47.730 99.621 63.798
201506 48.266 100.684 63.833
201509 49.210 100.392 65.271
201512 0.000 99.792 0.000
201609 52.787 101.861 69.005
201612 53.698 101.863 70.195
201703 54.872 102.862 71.033
201706 56.202 103.349 72.412
201709 57.596 104.136 73.647
201712 57.970 104.011 74.214
201803 59.326 105.290 75.028
201806 60.707 106.317 76.033
201809 62.352 106.507 77.954
201812 62.860 105.998 78.966
201903 64.538 107.251 80.127
201906 66.325 108.070 81.722
201909 68.262 108.329 83.907
201912 68.783 108.420 84.476
202003 70.801 108.902 86.570
202006 72.841 108.767 89.175
202009 75.255 109.815 91.251
202012 76.447 109.897 92.627
202103 79.732 111.754 95.002
202106 83.007 114.631 96.422
202109 86.311 115.734 99.304
202112 86.655 117.630 98.094
202203 89.129 121.301 97.841
202206 91.010 125.017 96.936
202209 94.247 125.227 100.216
202212 93.522 125.222 99.448
202303 95.654 127.348 100.018
202306 97.914 128.729 101.282
202309 0.000 129.860 0.000
202312 101.110 129.419 104.030
202403 104.169 131.776 105.261
202406 107.484 132.554 107.973
202409 111.252 133.029 111.359
202412 111.354 133.157 111.354

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beximco Pharmaceuticals  (DHA:BXPHARMA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Beximco Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.

Beximco Pharmaceuticals Headlines

No Headlines